JPH0344321A - 抗高血圧症および抗うっ血性心不全用の医薬組成物 - Google Patents

抗高血圧症および抗うっ血性心不全用の医薬組成物

Info

Publication number
JPH0344321A
JPH0344321A JP2177203A JP17720390A JPH0344321A JP H0344321 A JPH0344321 A JP H0344321A JP 2177203 A JP2177203 A JP 2177203A JP 17720390 A JP17720390 A JP 17720390A JP H0344321 A JPH0344321 A JP H0344321A
Authority
JP
Japan
Prior art keywords
hydroxy
dihydro
benzopyran
trans
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2177203A
Other languages
English (en)
Japanese (ja)
Inventor
Robert Paul Hof
ロベルト・パウル・ホフ
Quast Ulrich
ウルリッヒ・クヴァスト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPH0344321A publication Critical patent/JPH0344321A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2177203A 1989-07-04 1990-07-03 抗高血圧症および抗うっ血性心不全用の医薬組成物 Pending JPH0344321A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898915315A GB8915315D0 (en) 1989-07-04 1989-07-04 Pharmaceutical compositions for use against hypertension and congestive heart failure
GB8915315.9 1989-07-04

Publications (1)

Publication Number Publication Date
JPH0344321A true JPH0344321A (ja) 1991-02-26

Family

ID=10659511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2177203A Pending JPH0344321A (ja) 1989-07-04 1990-07-03 抗高血圧症および抗うっ血性心不全用の医薬組成物

Country Status (8)

Country Link
JP (1) JPH0344321A (https=)
BE (1) BE1004478A4 (https=)
CH (1) CH679641A5 (https=)
DE (1) DE4020133A1 (https=)
FR (1) FR2649320A1 (https=)
GB (2) GB8915315D0 (https=)
IE (1) IE902409A1 (https=)
IT (1) IT1241456B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008523145A (ja) 2004-12-13 2008-07-03 イーライ リリー アンド カンパニー リポキシゲナーゼ阻害剤としてのスピロ誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3776111D1 (de) * 1986-12-06 1992-02-27 Beecham Group Plc Pharmazeutische zubereitungen.
CH674984A5 (https=) * 1987-05-16 1990-08-15 Sandoz Ag
DE3815325A1 (de) * 1987-05-16 1988-11-24 Sandoz Ag Benzo(b)pyrane, pyranopyridine und pyranopyrimidine, verfahren zu deren herstellung und deren verwendung in arzneimitteln und kosmetika

Also Published As

Publication number Publication date
FR2649320A1 (fr) 1991-01-11
IE902409A1 (en) 1991-06-19
IT9048106A1 (it) 1992-01-03
BE1004478A4 (fr) 1992-12-01
IT1241456B (it) 1994-01-17
GB9014705D0 (en) 1990-08-22
CH679641A5 (https=) 1992-03-31
IT9048106A0 (it) 1990-07-03
GB2235382A (en) 1991-03-06
GB8915315D0 (en) 1989-08-23
DE4020133A1 (de) 1991-01-17

Similar Documents

Publication Publication Date Title
EP2702054B1 (en) Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
US20090270341A1 (en) Product comprising a transduction inhibitor of heterotrimeric g protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer
JP2930252B2 (ja) アンジオテンシン−▲ｉｉ▼受容体拮抗剤およびカルシウムチャンネルブロッカーの新規組成物
HUE034869T2 (en) Combination therapy with substituted oxazolidinones
US8440678B2 (en) Pharmaceutical composition
TWI741286B (zh) 治療癌症之方法
BG107812A (bg) Комбинация на гамк агонист и инхибитори на алдозна редуктаза
WO2020260463A1 (en) Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamide
EP0431828B1 (en) Improvements relating to the administration of pharmaceutical agents
US6436944B1 (en) Combination effective for the treatment of impotence
JPH08511253A (ja) アンギオテンシン変換酵素阻害剤とａ▲ｉｉ▼アンタゴニストとの組み合わせ
ZA200509311B (en) Method of improved diuresis in individuals with impaired renal function
US4469690A (en) Synergistic compositions of renal dopaminergic agent and β-blocker
JPS647045B2 (https=)
JPH0344321A (ja) 抗高血圧症および抗うっ血性心不全用の医薬組成物
WO2007056454A2 (en) Use of cicletanine and other furopyridines for treatment of hypertension
TW202327582A (zh) ＡＲＮｉ與鈣離子拮抗劑的藥物組合物及其用途
AU2008356312B2 (en) Antitumor agent, kit, and method for treating cancer
EP0433683A2 (en) Use of benzothiazepines as potentiators of anti-cancer drugs
JPH02121925A (ja) 腎ドーパミン様作用剤とアンジオテンシン変換酵素抑制剤の相乗作用を有する組成物
US20040138207A1 (en) Antitumor agents
EP0759298B1 (en) Use of 4-amino-6-hydroxypyrazolo[3,4-d]pyrimidine for the manufacture of an antihypertensive agent
KR960005145B1 (ko) 고혈압 및 울혈성 심부전증 치료용 약학적 조성물
WO2024254156A1 (en) Treatment of endometrial cancer with mdm2 inhibitors
EA049529B1 (ru) Фармацевтическая композиция, содержащая арни и антагонист ионов кальция, и ее применение